Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohnʼs Disease-Reference-Cited by-同舟云学术

Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohnʼs Disease

Published:2017-03 Issue:3 Volume:23 Page:461-472
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Coward Stephanie,Kuenzig M. Ellen,Hazlewood Glen,Clement Fiona,McBrien Kerry,Holmes Rebecca,Panaccione Remo,Ghosh Subrata,Seow Cynthia H.,Rezaie Ali,Kaplan Gilaad G.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference33 articles.

1. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

2. The global burden of IBD: from 2015 to 2025

3. Inflammatory Bowel Disease: A Canadian Burden of Illness Review

4. Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

5. Management of Crohn's Disease in Adults

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems;Pharmaceutics;2024-09-07

2. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment;Journal of Crohn's and Colitis;2024-06-15

3. Early and aggressive treatment for Crohn disease using biologics and immunomodulators;JAAPA;2024-04-25

4. New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases;Therapeutic Advances in Gastroenterology;2024-01

5. Integration of an Aptamer-Based Signal-On Probe and a Paper-Based Origami Preconcentrator for Small Molecule Biomarkers Detection;BioChip Journal;2023-09-21